Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients

Clinical Respiratory Journal

Volumn 7, Issue 3, 2013, Pages 227-236

  Hager, W David ^a   Collins, Irina ^a   Tate, Janet P ^a   Azrin, Michael ^a   Foley, Raymond ^a   Lakshminarayanan, Santha ^a   Rothfield, Naomi F ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Diastolic dysfunction; Exercise induced pulmonary arterial hypertension; Pulmonary hypertension; Scleroderma; Systemic sclerosis

Indexed keywords

ADULT; ARM EXERCISE; ARTICLE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HAND; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HEART OUTPUT; HEMODYNAMICS; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LUNG ARTERY PRESSURE; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STRESS; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE;

DIASTOLIC DYSFUNCTION; EXERCISE-INDUCED PULMONARY ARTERIAL HYPERTENSION; PULMONARY HYPERTENSION; SCLERODERMA; SYSTEMIC SCLEROSIS;

ADULT; AGED; CARDIAC CATHETERIZATION; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; EXERCISE; EXERCISE TEST; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE; REGISTRIES; SCLERODERMA, SYSTEMIC; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84880146612     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2012.00310.x     Document Type: Article

References (42)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360: 1989-2003.
2. Condliffe R, Kiely DG, Peacock AJ, etal. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009;179: 151-157.
3. Campo A, Mathai SC, Le Pavec J, etal. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;182: 252-260.
4. MacGregor AJ, Canavan R, Knight C, Denton CP, Davar J, Coglan J, Black CM. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology. 2001;40: 453-459.
5. Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survivial in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest. 2003;123: 344-350.
6. Armstrong GP, Whalley GA, Doughty RN, Gamble GD, Flett SM, Tan PL, Sharpe DN. Left ventricular function in scleroderma. Br J Rheumatol. 1996;35: 983-988.
7. Fernandes F, Ramires FJA, Arteaga E, Ianni BM, Bonfa ESDO, Mady C. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail. 2003;9: 311-317.
8. Champion HC. The heart in scleroderma. Rheum Dis Clin North Am. 2008;34: 181-190.
9. Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology. 2009;48: 45-48.
10. Walkey AJ, Ieong M, Alikhan MIR, Farber HW. Cardiopulmonary exercise testing with right-heart catheterization in patients with systemic sclerosis. J Rheumatol. 2010;37: 1871-1877.
11. Steen V, Chou M, Shanmugam V, Mathias M, Kuru T, Morrissey R. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest. 2008;134: 146-151.
12. Kovacs G, Maier R, Aberer E, etal. Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization. Chest. 2010;138: 270-278.
13. Hachulla E, Groote PD, Gressin V, etal. The three year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum. 2009;60: 1831-1839.
14. Yiu KH, Schouffoer AA, Marsan NA, etal. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis. Arthritis Rheum. 2011;63: 3969-3978.
15. Kovacs G, Maier R, Aberer E, etal. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med. 2009;180: 881-886.
16. Alkotob ML, Soltani P, Sheatt MA, Katsetos MC, Rothfield N, Hager WD, Foley RJ, Silverman DI. Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. Chest. 2006;130: 176-181.
17. Morelli S, Ferrante L, Sgreccia A, Eleuter ML, Perrone C, DeMarzio P, Balsano F. Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis. Scand J Rheumatol. 2000;29: 236-242.
18. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM. Exercise-induced pulmonary arterial hypertension. Circulation. 2008;118: 2183-2189.
19. Badesch DB, Champion HC, Sanchez MA, etal. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54: S55-S66.
20. Borlaug BA, Nishimura RA, Sorajja P, Lam D, Redfield MM. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail. 2010;3: 588-595.
21. Lewis GD. Pulmonary vascular response patterns to exercise: is there a role for pulmonary arterial pressure assessment during exercise in the post-Dana Point eras? Adv Pulm Hypertens. 2010;9: 92-100.
22. Yang SS, Bentivoglio LG, Maranhao V, Goldberrg H. Basic measurements and calculations, cardiac output and flow resistance. In: Cardiac Catheterization Data to Hemodynamic Parameters. Philadelphia, PA, FA David Company, 1978: 1-93.
23. Saggar R, Khanna D, Furst DE, etal. Exercise-induced pulmonary hypertension associated with systemic sclerosis. Arthritis Rheum. 2010;62: 3741-3750.
24. Humbert M, Yaici A, de Groote P, etal. Screening for pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum. 2011;63: 3522-3530.
25. West JB. Left ventricular filling pressures during exercise - a cardiological blind spot? Chest. 1998;113: 1695-1697.
26. Bevegard S, Holmgren A, Jonsson B. Circulatory studies in well trained athletes at rest and during heavy exercise, with special reference to stroke volume and the influence of body position. Acta Physiol Scand. 1963;57: 26-50.
27. Thadani U, Parker JO. Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects. Am J Cardiol. 1978;41: 52-59.
28. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009;34: 888-894.
29. Bossone E, Rubenfire M, Bach DS, Ricciardi M, Armstrong WF. Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension. J Am Coll Cardiol. 1999;33: 1662-1666.
30. Granath A, Jonsson B, Strandell T. Circulation in healthy old men, studied by right heart catheterization at rest and during exercise in supine and sitting position. Acta Med Scand. 1964;176: 425-446.
31. Steen V, Medsger TA. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum. 2003;48: 516-522.
32. Steen VD, Lucas M, Fertig N, Medsger TA. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody. J Rheumatol. 2007;34: 2230-2235.
33. Oudiz RJ, Rubin LJ. Exercise-induced pulmonary arterial hypertension: a new addition to the spectrum of pulmonary vascular diseases. Circulation. 2008;118: 2120-2121.
34. Lakshminarayanan S, Shaban N, Tran T, Ryan JW, Collins I, Hager D, Rothfield NF. Echo-Doppler evaluation does not show abnormal diastole in scleroderma patients with pulmonary venous hypertension. Arthritis Rheum. 2011;63: S277.
35. Maeder MT, Thompson BR, Brunner-LaRocca HP, Kaye DM. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol. 2010;56: 855-863.
36. Penicka M, Bartunek J, Trakalova H, Hrabakova H, Muruskova HM, Karasek J, Kocka V. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea. J Am Coll Cardiol. 2010;55: 1701-1710.
37. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2009;53: 1119-1126.
38. Hachulla AL, Launay D, Gaxotte V, deGroote P, Lambin N, Devos P, Hatron PY, Beregi JP, Hachulla E. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis. 2009;68: 1878-1884.
39. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, Gialafos E, Moyssakis I, Moutsopoulos HM. Pattern and distribution of myocardial fibrosis in systemic sclerosis. Arthritis Rheum. 2007;56: 3827-3836.
40. Edelmann F, Gelbrich G, Dungen HD, etal. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction. J Am Coll Cardiol. 2011;58: 1780-1791.
41. Clinical trials.gov. NCT00094302 Aldosterone Antagonist Therapy for Adults with Heart Failure and Preserved Systolic Function (TOPCAT)
42. Clinical trials.gov. NCT00763867 Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People with Diastolic Heart Failure (The RELAX Study)